Ads
    Related paper
  1. Endothelial function in patients with diabetes mellitus type 2 with arterial hypertension in good compensation of hyperglycemia
  2. DAMAGE OF RENAL FUNCTION AND DYNAMICS OF DYSLIPIDEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH INSUFFICIENT GLYCEMIC COMPENSATION UNDER CONDITION OF CORRECTION OF HYPERTENSION WITH ANGIOTENSIN II RECEPTOR ANTAGONISTS
  3. An experience of application of telmisartan (micardis) in therapy of patients with diabetes mellitus type 2, diabetic nephropathya and arterial hypertension
  4. UNIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA AS A POTENTIAL PREDICTOR OF ARTERIAL HYPERTENSION DEVELOPMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
  5. EFFECT OF DAPAGLIFLOZIN ON THE LEVEL OF URIC ACID DURING ASYMPTOMATIC HYPERURICEMIA IN PATIENTS WITH DIABETES MELLITUS TYPE 2 AND CONCOMITANT ARTERIAL HYPERTENSION
  6. GLUCOSE METABOLISM CHARACTERISTICS AND THE I/D GENE POLYMORPHISM OF THE ANGIOTENSIN-CONVERTING ENZYME IN THE PATIENTS WITH ARTERIAL HYPERTENSION ACCOMPANYING WITH A TYPE II DIABETES MELLITUS
  7. CHARACTERISTICS OF DAILY PROFILE OF ARTERIAL PRESSURE IN PATIENTS WITH DIABETES MELLITUS ASSOCIATED WITH ARTERIAL HYPERTENSION
  8. Relationship of endothelial dysfunction with degree of renal function damage and lipidemic profile in patients with type 2 diabetes mellitus and hypertension
  9. Dynamics of endothelial dysfunction, nephropathic and dyslipidemic disorders in patients with insufficient glycemic compensation of type 2 diabetes mellitus during 1 year of application of angiotensin II receptor antagonists for hypertension correction
  10. PECULIARITIES OF PATHOGENESIS OF COMORBID ARTERIAL HYPERTENSION AND DIABETES MELLITUS 2 TYPE